Mr Daniel Cohen

Daniel Cohen is a Consultant Urological Surgeon who specialises in the diagnosis and treatment of prostate and bladder problems, including Holmium Laser (HoLEP) surgery for benign prostate hypertrophy, mpMRI guided biopsies for the diagnosis of prostate cancer, and diagnosis and treatment of bladder cancer and benign bladder problems.

Specialties and sub-specialties

Urology

Holmium Laser Enucleation of Prostate

Sctrotal and testicular problems

Incontinence

Blood in urine (Haematuria)

Urinary tract infection

Treatments

Bladder neck incision

Prostate artery embolisation for benign prostatic hyperplasia

TURP

Professional profile

Daniel Cohen is a Consultant Urological Surgeon. After completing a PhD in the Division of Surgery at Imperial College London, he undertook surgical training in London and completed a fellowship in laser prostate (HoLEP) and stone surgery.

His main clinical interests are in the diagnosis and management of prostate and bladder cancers, benign prostate enlargement and bladder function disorders in men and women, in addition to a general urology practice covering stone disease, scrotal and testicular problems and urological emergencies.

Mr Cohen co-authors the European Association of Urology bladder cancer guidelines and is an advisor to Prostate Cancer UK. He is a core member of the prostate and bladder multidisciplinary teams at Royal Free London NHS Foundation Trust.

Mr Cohen has published over 20 peer-reviewed papers and presented at medical and industry conferences in the UK, Europe and the USA. He was awarded a Distinction for his research by the Association of Surgical Education in the USA.

Clinical interests

Benign Prostate Hypertrophy

Current posts

Consultant Urological Surgeon
Royal Free London NHS Foundation Trust

Awards and accolades

Distinction - Association of Surgical Education (USA).

Medical training

Year qualified 2004

University of Birmingham 2004

Publications

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
Authors: Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V
Year: 2019
Published by: European Urology

Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel
Authors: Soukup V, Čapoun O, Cohen D, Hernández V, Burger M, Compérat E, Gontero P, Lam T, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R, Babjuk M.
Year: 2020
Published by: European Urology Focus

Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: An EAU Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
Authors: Soukup V, Čapoun O, Cohen D, Hernández V, Babjuk M, Burger M, Compérat E, Gontero P, Lam T, MacLennan S, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R.
Year: 2017
Published by: European Urology